当前位置:首页 - 行情中心 - 九强生物(300406) - 财务分析 - 现金流量表

九强生物

(300406)

  

流通市值:54.82亿  总市值:75.75亿
流通股本:4.24亿   总股本:5.86亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金336,831,910.181,592,602,979.541,198,144,986.79789,809,846.24
  收到的税费返还-172,513.55172,513.55172,513.55
  收到其他与经营活动有关的现金5,189,089.5422,554,276.0610,755,497.188,374,369.16
  经营活动现金流入小计342,020,999.721,615,329,769.151,209,072,997.52798,356,728.95
  购买商品、接受劳务支付的现金67,502,608.49291,957,694226,254,284.44156,484,443.08
  支付给职工以及为职工支付的现金100,262,384.08317,791,513.75256,568,356.54195,158,215.5
  支付的各项税费46,519,357.94197,849,182.41152,406,070.55106,822,151.94
  支付其他与经营活动有关的现金32,230,412.45242,621,628.02147,010,714.895,815,267.71
  经营活动现金流出小计246,514,762.961,050,220,018.18782,239,426.33554,280,078.23
  经营活动产生的现金流量净额95,506,236.76565,109,750.97426,833,571.19244,076,650.72
二、投资活动产生的现金流量:
  收回投资收到的现金50,000,00073,000,00020,000,00019,760,000
  取得投资收益收到的现金325,000571,347.27279,736.12245,541.71
  处置固定资产、无形资产和其他长期资产收回的现金净额5,70061,294153,529147,544
  处置子公司及其他营业单位收到的现金净额-0-0
  收到的其他与投资活动有关的现金-023,291,611.1523,000,000
  投资活动现金流入小计50,330,70073,632,641.2743,724,876.2743,153,085.71
  购建固定资产、无形资产和其他长期资产支付的现金9,107,025.6839,240,751.1930,312,420.4823,083,794.81
  投资支付的现金-459,711,944.67263,000,000213,000,000
  取得子公司及其他营业单位支付的现金-0-0
  支付其他与投资活动有关的现金-50,000,000-0
  投资活动现金流出小计9,107,025.68548,952,695.86293,312,420.48236,083,794.81
  投资活动产生的现金流量净额41,223,674.32-475,320,054.59-249,587,544.21-192,930,709.1
三、筹资活动产生的现金流量:
  吸收投资收到的现金--281,271.5283,373.47
  其中:子公司吸收少数股东投资收到的现金--281,271.5283,373.47
  取得借款收到的现金355,177.091,318,001.34998,487.31826,578.63
  收到其他与筹资活动有关的现金-6,171,412.614,888,660.633,323,979.47
  筹资活动现金流入小计355,177.097,489,413.956,168,419.444,433,931.57
  偿还债务支付的现金342,967.74127,419,550.98127,170,792.217,413,500.73
  分配股利、利润或偿付利息支付的现金2,639,404540,152,925.64423,454,639.34248,495,056.88
  其中:子公司支付给少数股东的股利、利润2,639,4043,011,0643,011,0643,011,064
  支付其他与筹资活动有关的现金208,312.220,730,183.6919,863,374.9919,320,466.09
  筹资活动现金流出小计3,190,683.94688,302,660.31570,488,806.53285,229,023.7
  筹资活动产生的现金流量净额-2,835,506.85-680,813,246.36-564,320,387.09-280,795,092.13
四、汇率变动对现金及现金等价物的影响-194,057.48-389,715.5-164,996.95-72,861.86
五、现金及现金等价物净增加额133,700,346.75-591,413,265.48-387,239,357.06-229,722,012.37
  加:期初现金及现金等价物余额539,645,136.361,131,058,401.841,131,058,401.841,131,058,401.84
  期末现金及现金等价物余额673,345,483.11539,645,136.36743,819,044.78901,336,389.47
补充资料:
  净利润-190,537,287.77-175,713,965.16
  资产减值准备-207,340,661.85-11,802,212.65
  固定资产和投资性房地产折旧-59,779,575.08-30,099,664.85
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-59,779,575.08-30,099,664.85
  无形资产摊销-10,310,634.48-4,861,245.86
  长期待摊费用摊销-492,048.26-237,499.45
  处置固定资产、无形资产和其他长期资产的损失-2,872,916.43-749,603.05
  固定资产报废损失-830,079.58-598,201.16
  公允价值变动损失-0--
  财务费用-49,832,952.55-23,783,087.71
  投资损失--12,135,601.29-742,471.47
  递延所得税--9,671,517.68--2,765,621.75
  其中:递延所得税资产减少--8,769,308.6--2,096,873.72
    递延所得税负债增加--902,209.08--668,748.03
  存货的减少-20,902,666.99-664,846.3
  经营性应收项目的减少-100,069,630.45-41,371,147.07
  经营性应付项目的增加--57,577,720.62--44,542,020.32
  一年内到期的可转换公司债券-8,407,665.78--
  现金的期末余额-539,645,136.36-878,336,389.47
  减:现金的期初余额-1,042,657,721.31-1,042,657,721.31
  加:现金等价物的期末余额---23,000,000
  减:现金等价物的期初余额-88,400,680.53-88,400,680.53
  现金及现金等价物的净增加额--591,413,265.48--229,722,012.37
公告日期2026-04-272026-04-272025-10-292025-08-27
审计意见(境内)标准无保留意见
TOP↑